NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Studies by K.L. Gorringe and co-authors describe new findings in breast cancer



November 27th, 2008

"Mutations in BRCA1 predispose to breast cancer," scientists in Melbourne, Australia report.

"CTIP interacts with BRCA1 and so could also be associated with increased risk. We screened CTIP for germline mutations in 210 probands of breast cancer families including 129 families with no mutations in BRCA1 or BRCA2," wrote K.L. Gorringe and colleagues.

The researchers concluded: "No coding variants were detected in CTIP, therefore, it is unlikely to be involved in breast cancer risk."

Gorringe and colleagues published their study in Breast Cancer Research and Treatment (Breast cancer risk and the BRCA1 interacting protein...


Source: Women's Health Weekly (2008-11-27)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login